SPY311.36-0.82 -0.26%
DIA263.33+0.16 0.06%
IXIC9,615.81-67.10 -0.69%
News
MASI
--
0.00%
--
Why Is Masimo (MASI) Up 5.3% Since Last Earnings Report?
Zacks · 05/28 16:31
Philips in-licenses new Masimo technologies for patient monitors
Seeking Alpha - Article · 05/27 14:04
Masimo and Philips Licensing Agreement Brings Masimo NomoLine® Capnography and O3® Regional Oximetry to Select Philips Patient Monitors
Philips is integrating additional Masimo monitoring technologies into select Philips multi-parameter patient monitors.
Business Wire · 05/27 12:00
Masimo Announces 2020 Annual Meeting of Stockholders to be Held as a Virtual Meeting
Masimo Corporation (Nasdaq: MASI) today announced a change to its 2020 Annual Meeting of Stockholders. Due to conditions associated with the Coronavirus pandemic (COVID-19), including restrictions on in-person gatherings, and in order to support the health and
Business Wire · 05/21 00:00
Here's Why You Should Retain Masimo Stock (MASI) For Now
Zacks · 05/18 16:11
The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12)
Benzinga · 05/13 11:40
Stocks That Hit 52-Week Highs On Tuesday
Tuesday morning saw 85 companies set new 52-week highs.
Benzinga · 05/12 14:41
Stocks That Hit 52-Week Highs On Monday
Monday's morning session saw 70 companies set new 52-week highs.
Benzinga · 05/11 14:29
Masimo to Present in UBS Virtual Global Healthcare Conference
Masimo (NASDAQ: MASI) today announced that its management is scheduled to present in the UBS Virtual Global Healthcare Conference on Monday, May 18, 2020 at 4:40 p.m. Eastern Time. A live audiocast of the presentation will be available on the Masimo website at
Business Wire · 05/11 13:00
This Top Invesco Fund Finds Gems Amid Market Rubble
Investor's Business Daily · 05/08 16:32
Stocks That Hit 52-Week Highs On Thursday
During Thursday's morning session, 55 companies made new 52-week highs.
Benzinga · 05/07 14:33
How Does Masimo's (NASDAQ:MASI) P/E Compare To Its Industry, After Its Big Share Price Gain?
Simply Wall St. · 05/07 12:46
The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs May 6.)
Benzinga · 05/07 11:42
Masimo Stock Jumps as its Medical Products Are in High Demand
TheStreet.com · 05/06 14:48
The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech Stocks Hitting 52-week Highs May 5)
Benzinga · 05/06 14:36
Announcing: Masimo (NASDAQ:MASI) Stock Soared An Exciting 578% In The Last Five Years
Simply Wall St. · 05/06 13:10
Edited Transcript of MASI earnings conference call or presentation 28-Apr-20 8:30pm GMT
Thomson Reuters StreetEvents · 05/04 14:39
Study Finds Noninvasive, Continuous Masimo PVi® Monitoring More Valuable Than Central Venous Pressure Measurement for Guiding Fluid Management During Surgery
A new study compared Masimo PVi® and CVP and found that PVi was more valuable for guiding fluid management during surgery.
Business Wire · 05/04 06:00
UBS Maintains Buy on Masimo, Raises Price Target to $245
UBS maintains Masimo (NASDAQ:MASI) with a Buy and raises the price target from $207 to $245.
Benzinga · 04/30 13:40
Masimo (MASI) Q1 Earnings Beat Estimates, Margins Expand
Zacks · 04/29 15:39